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A B S T R A C T   
The basal ganglia (BG) are involved in cognitive/motivational functions in addition to movement control. Thus, 
BG segregated circuits, the sensorimotor (SM) and medial prefrontal (mPF) circuits, process different functional 
domains, such as motor and cognitive/motivational behaviours, respectively. With a high presence in the BG, the 
CB1 cannabinoid receptor modulates BG circuits. Furthermore, dopamine (DA), one of the principal neuro-
transmitters in the BG, also plays a key role in circuit functionality. Taking into account the interaction between 
DA and the endocannabinoid system at the BG level, we investigated the functioning of BG circuits and their 
modulation by the CB1 receptor under DA-depleted conditions. We performed single-unit extracellular re-
cordings of substantia nigra pars reticulata (SNr) neurons with simultaneous cortical stimulation in sham and 6- 
hydroxydopamine (6-OHDA)-lesioned rats, together with immunohistochemical assays. We showed that DA 
loss alters cortico-nigral information processing in both circuits, with a predominant transmission through the 
hyperdirect pathway in the SM circuit and an increased transmission through the direct pathway in the mPF 
circuit. Moreover, although DA denervation does not change CB1 receptor density, it impairs its functionality, 
leading to a lack of modulation. These data highlight an abnormal transfer of information through the asso-
ciative/limbic domains after DA denervation that may be related to the non-motor symptoms manifested by 
Parkinson’s disease patients.   
1. Introduction 
Although, for a long time, the basal ganglia (BG) have been viewed 
exclusively as motor control structures, they are a highly organized 
network that integrates information from several cortical areas, con-
forming to segregated parallel anatomical circuits that process different 
functional domains. Thus, while sensorimotor (SM) circuits play a 
crucial role in motor functions, medial prefrontal (mPF) circuits are 
related to cognitive and motivational information processing (Alexander 
et al., 1986; Haber, 2003; Middleton and Strick, 2000; Parent and 
Hazrati, 1995). CB1 cannabinoid receptors are highly expressed in the 
BG, as well as in other parts of the brain (Herkenham et al., 1991; Köfalvi 
et al., 2005; Mailleux and Vanderhaeghen, 1992; Julián Romero et al., 
2002; Tsou et al., 1998). Interestingly, CB1 receptor activation differ-
entially modulates cortical information transfer through both circuits, 
decreasing SM information transmission through the trans-striatal 
pathways and profoundly hindering cortico-nigral transmission 
through the mPF circuits (Antonazzo et al., 2019). Some of the effects 
found after acute and chronic exposure to cannabis extracts, such as 
motor performance deficits (slower reaction time or inappropriate 
motor coordination) and neurocognitive functioning impairments (in 
memory, associative learning, task switching or attention) (Grant et al., 
2003; Prashad and Filbey, 2017; Schreiner and Dunn, 2012), have been 
related to the activation of the CB1 receptor. 
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Dopamine (DA), as one of the principal neurotransmitters in the BG, 
plays a key role in circuitry functionality (Tremblay et al., 2015). In fact, 
perturbations in DA neurotransmission at the level of the striatum 
contribute to maladaptive processing within the BG and lead not only to 
movement disorders, such as Parkinson’s disease (PD), but also to 
several neuropsychiatric diseases (Tremblay et al., 2015). Substantial 
evidence supports neuroanatomical and direct/indirect functional in-
teractions between the DA system and the endocannabinoid system in 
the BG: CB1 receptors form heteromers with DA receptors in striatal 
projection neurons (Ferré et al., 2009) cannabinoids increase nigros-
triatal DA neuronal firing and synaptic DA release in the striatum, 
mainly through (Morera-Herreras et al., 2012) CB1 receptors present in 
GABAergic and glutamatergic terminals [for review see (García et al., 
2016)] DA modulates endocannabinoid release in the striatum (Giuf-
frida et al., 1999; Patel et al., 2003); and there is altered endocannabi-
noid signalling in the BG after DA depletion [details in (Morera-Herreras 
et al., 2012)]. 
Considering these findings, we further investigated the impact of DA 
loss on cortical information transmission through the SM and mPF cir-
cuits of the BG and its regulation by the CB1 receptor. For this purpose, 
simultaneous cortical electrical stimulation and single-unit extracellular 
recordings of substantia nigra pars reticulata (SNr) neurons were carried 
out in anaesthetized sham and 6-hydroxydopamine (6-OHDA)-lesioned 
rats. 
2. Materials and methods 
2.1. Animals 
Male Sprague-Dawley rats (160–215 g at the beginning of the ex-
periments) were housed in groups of 4 under standard laboratory con-
ditions (22 ± 1 ◦C, 55% ± 5% relative humidity, and 12:12 h light/dark 
cycle) with food and water provided ad libitum. The experimental 
protocols were reviewed and approved by the Local Ethical Committee 
for Animal Research of the University of the Basque Country (UPV/EHU, 
CEEA, ref. ES48/054000/6069). All of the experiments were performed 
in accordance with the European Community Council Directive on “The 
Protection of Animals Used for Scientific Purposes” (2010/63/EU) and 
with Spanish Law (RD 53/2013) for the care and use of laboratory 
animals. 
2.2. Drugs 
6-OHDA, desipramine hydrochloride, WIN 55,212-2 and chloral 
hydrate were obtained from Sigma-Aldrich. AM251 was obtained from 
Tocris Bioscience. Desipramine and chloral hydrate were prepared in 
0.9% saline. 6-OHDA was dissolved in Milli-Q water containing 0.02% 
ascorbic acid. WIN 55,212-2 and AM251 were diluted in 1:1:18 cre-
mophor/ethanol/saline solution. All drugs were prepared on the day of 
the experiment. 
2.3. 6-Hydroxydopamine lesion 
Unilateral 6-OHDA injection in the medial forebrain bundle (MFB) 
was performed, as previously described (Aristieta et al., 2016, 2019). 
Thirty minutes before stereotaxic surgery, rats were pretreated with 
desipramine (25 mg/kg, i.p.) in order to protect noradrenergic terminals 
from 6-OHDA toxicity. Rats were deeply anaesthetized with isoflurane 
inhalation (4% for induction; 1.5%–2% for maintenance) and placed in a 
stereotaxic frame (David Kopf® Instruments). Lesions were performed 
by two injections of 6-OHDA of 8.75 and 7 μg, respectively (3.5 μg/μl 
saline with 0.02% ascorbic acid) in the right medial forebrain bundle: 
2.5 μl at anteroposterior (AP) − 4.4 mm, mediolateral (ML) +1.2 mm and 
dorsoventral (DV) − 7.8 mm, relative to bregma and dura with the 
toothbar set at − 2.4, and 2 μl at AP − 4.0 mm, ML +0.8 mm, and DV − 8 
mm, with toothbar at +3.4 (Paxinos and Watson, 2006). For the 
administration of the neurotoxin a 10 μl-Hamilton syringe coupled to a 
pump at an infusion rate of 1 μl/min. Sham animals were similarly 
treated but instead of 6-OHDA received vehicle. Rats were randomized 
to receive either vehicle or 6-OHDA infusion. Electrophysiological ex-
periments were performed 4–5 weeks after the lesion. 
2.4. Cylinder test 
Forelimb use asymmetry was assessed 4 weeks post-surgery as 
indicative of severe dopaminergic damage using the cylinder test, as 
previously described (Hernando et al., 2019). Rats were individually 
placed in a 20 cm diameter methacrylate cylinder and allowed to 
explore freely. Mirrors were placed behind the cylinder to allow a 360◦
view of the exploratory behavior. Each animal was left in place until at 
least 20 supporting front paw touches with open digits were done on the 
walls of the cylinder. The session was video-recorded for posterior 
analysis. Touches performed with the front limb contralateral or ipsi-
lateral to the lesioned hemisphere were counted, and data expressed as 
the percentage of ipsilateral placement. Rats using the ipsilateral paw 
above 70% were considered to have severe damage of the dopaminergic 
system. Breakdown of these data into the different experimental groups 
is found in Table S1 and illustrated in the Fig. 1B. 
2.5. Electrophysiological procedures 
The electrophysiological procedures, schematically illustrated in 
Fig. 1, were performed as previously described (Antonazzo et al., 2019). 
Animals were anaesthetized with chloral hydrate (420 mg/kg, i.p.) for 
induction, followed by continuous administration (i.p.) of chloral hy-
drate at a rate of 115.5 mg/kg/h using a peristaltic pump to keep a 
steady level of anaesthesia. For additional drug administration, the right 
jugular vein was cannulated. The animal body temperature was main-
tained at ~37 ◦C for the entire experiment with a heating pad connected 
to a rectal probe. The rat was placed in a stereotaxic frame with its head 
secured in a horizontal orientation. The skull was exposed, and two 3- 
mm burr holes were drilled over the right SNr and the ipsilateral 
motor cortex (MC) or anterior cingulate cortex (ACC). 
Single-unit extracellular recordings were made by an Omegadot 
single glass micropipette, pulled with an electrode puller (Narishige 
Scientific Instrument Lab., PE-2, Japan), broken back to a tip diameter of 
1–2.5 μm under a light microscope and filled with 2% Pontamine Sky 
Blue in 0.5% sodium acetate. This electrode was lowered into the SM 
(5.8 mm posterior to Bregma, 2.5 mm lateral to midline, and 7–8 mm 
ventral to the dura mater) or mPF territory (5.4 mm posterior to Bregma, 
1.8 mm lateral to midline, and 7–8 mm ventral to the dura mater) of the 
SNr. To evoke triphasic responses in SNr neurons, the MC (3.5 mm 
anterior to Bregma, 3.2 mm lateral to midline, and 1.6 mm ventral to the 
dura mater) or the ACC (2.9 mm anterior to Bregma, 0.6 mm lateral to 
midline, and 1.7 ventral to the dura mater) ipsilateral to the recording 
site, was stimulated at 1 Hz (pulse width, 600 μs; intensity, 1 mA) using 
coaxial stainless-steel electrodes (diameter, 250 μm; tip diameter, 100 
μm; tip-to-barrel distance, 300 μm) during the recordings (Cibertec S. 
A.). 
The signal from the recording electrode passed through an AxoClamp 
2-B amplifier (Axon Instruments) bridge circuitry, amplified x100, and 
filtered at 300–3000 Hz with a high-input impedance amplifier 
(AMPLI64AC, Cibertec). The signal was monitored through an oscillo-
scope and an audio-monitor. Neuronal spikes were sampled at 25 kHz 
using a CED micro3 1401 analog-digital interface and a computer 
running Spike2 acquisition software (Cambridge Electronic Design, UK). 
SNr neurons were identified as non-dopaminergic by their classically 
defined electrophysiological characteristics: thin spikes (width, <2 ms) 
and ability to present relatively high-frequency discharges without 
decrease in spike amplitude (as described in Antonazzo et al. (2019)). 
Although multiple neurons were recorded in each animal in order to 
characterize the spontaneous and cortically evoked activity in both SM 
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and mPF territories, only one SNr cell was pharmacologically studied 
per animal. 
Firing parameters such as firing rate and coefficient of variation (CV) 
of SNr neurons were analysed offline using Spike2 software (version 7). 
The CV consisted on the ratio, expressed as a percentage, between the 
standard deviation and the mean of the neuron’s inter-spike interval 
histogram. This histogram was made with 1 ms bins, and considering all 
the inter-spike intervals below 0.5 ms, given the relatively high firing 
rate of SNr neurons. The existence of burst firing in neurons was 
determined through a Spike2 script (“surprise.s2s”), based on the Pois-
son surprise algorithm. These parameters were analysed during time 
epochs of 150 s under basal conditions, or for 120 s once the drug was 
administered. Before data analysis, spike-sorting procedures were used 
just to discriminate electrical stimulation artifacts from actual spikes, 
and discard them to avoid any interference with posterior analysis. This 
procedures were done using the Spike2 software, and consisted in 
principal component analysis and template matching to help discrimi-
nate, and group stimulation artifacts and spikes waveforms separately. 
The few spare waveforms that left ungrouped after this were manually 
inspected and grouped accordingly. Given the nature of our recordings, 
only single-units were recorded, and thus all the spikes present in the 
recordings were from the same unit. 
Peristimulus time histograms were generated from 180 stimulation 
trials using 1 ms bins. The criterion used to determine the existence of an 
excitatory response was a two-fold increase in the standard deviation 
over the pre-stimulus period, plus the mean number of spikes, for at least 
three consecutive bins. The amplitude of excitatory responses was 
quantified by calculating the difference between the mean number of 
spikes evoked within the time window of the excitation and the mean 
number of spikes occurring spontaneously before the stimulation. The 
duration of an inhibitory response corresponded to the time interval 
during which no spikes were observed for at least three consecutive bins. 
To better describe information transmission through these circuits, 
we set latency ranges for each pathway based on the latencies of tri-
phasic responses, since these inform of the transmission through the 
three pathways that constitute the circuits. Such ranges were set up to 
each cortically-evoked response (i.e. early excitation, EE; inhibition, 
INH, late excitation, LE), in each circuit (i.e. SM or mPF) and experi-
mental group (i.e. sham or 6-OHDA). For each response, a range was set 
according to the minimum and maximum latency observed within the 
triphasic-respondent neurons of that circuit and experimental group 
(Table S2). Hence, cortically evoked responses whose latency was out of 
this range were excluded from the analyses of the cortically evoked re-
sponses, and neurons with no cortically evoked response within range 
were excluded from all the analysis (cortically evoked and spontaneous 
firing parameters). 
As more than one neuron (1–15 per rat) was recorded per animal in 
the characterization of the SM and mPF circuits, electrophysiological 
parameters such as firing rate, coefficient of variation, and parameters 
related to cortically evoked responses (i.e. duration, latency and 
amplitude of the responses) were averaged per animal, so that every 
animal had one value for each electrophysiological parameter. 
2.6. Tyrosine hydroxylase immunohistochemistry 
Immediately after the electrophysiological procedure, animals were 
transcardially perfused with a phosphate-buffered saline solution fol-
lowed by 4% paraformaldehyde solution. Fixed brains were sliced at 40 
μm by a freezing microtome (HM 430, Microm) and stored in a cryo-
protective solution at − 20 ◦C until further processing. Tyrosine hy-
droxylase (TH)-immunostaining was used to examine the degree of DA 
denervation in the striatum and the SNc as previously described (Aris-
tieta et al., 2019, 2016). Free-floating sections were incubated in a 3% 
H2O2 + 10% MeOH solution prepared in potassium phosphate buffer 
saline with 0.1% Triton X-100 (KPBS-t) for 30 min. After that, sections 
were washed in KPBS and blocked with 5% normal goat serum (NGS) in 
KPBS-t during 1 h, and incubated with rabbit anti-TH (AB 152, 1:1000, 
Merck) primary antibody in 5% NGS-KPBS-t, at room temperature 
overnight. The sections were then washed in 2.5% NGS-KPBS-t, and 
incubated for 2 h with a biotinylated goat antibody against rabbit IgG 
(BA 1000, 1:200, Vector Laboratories) in 2.5% NGS-KPBS-t. Thereafter, 
sections were washed and incubated with an avidin–biotin–peroxidase 
complex (ABC kit, PK-6100, Vector Laboratories) and peroxidase ac-
tivity was visualized with 0.05% 3,3′-diaminobenzidine (Sigma) and 
0.03% H2O2. Finally, sections were mounted onto gelatin-coated slides, 
dehydrated, cleared with xylene and coverslipped. For the analysis, 
striatal sections from each animal (rostral, medial and caudal levels) 
were optically digitized using an EPSON V700 scanner at a resolution of 
6400 ppp, and the mean optical density (OD) associated with the 
striatum was calculated using NIH-produced image analysis software 
ImageJ (Schindelin et al., 2012). The OD was expressed as a percentage 
of that of the contralateral intact side (100%) with the background 
associated with the corpus callosum set as 0%. Only animals with >90% 
DA degeneration were included in the analysis. Breakdown of these data 
into the different experimental groups is found in Table S1 and illus-
trated in the Fig. 1B. 
2.7. CB1 receptor immunohistochemistry 
Another series of animals (sham and 6-OHDA lesioned rats) were 
used to determine the expression of CB1 receptors within the BG. Rats 
were transcardially perfused with a phosphate-buffered saline solution 
followed by a mixture of 4% paraformaldehyde and 0.5% glutaralde-
hyde with 2 ml per litre of a saturated solution of picric acid in 0.1 M 
phosphate buffer (PB; pH 7.4). Brains were extracted and stored in 
fixative solution for one week. After fixation, brains were coronally cut 
at 50 μm by a cryotome. 
Sections were preincubated in blocking solution containing 10% 
bovine serum albumin, 0.5% Triton X-100 and 0.1% sodium azide in 
Tris-HCl-buffered saline (TBS) for 30 min and then incubated in solution 
of primary goat antibody raised against CB1 cannabinoid receptor (CB1- 
Go-Af450 Frontier Institute Co.; RRID AB_257130) at a final dilution of 
Fig. 1. Schematic illustration of electrophysiological recordings in SNr neurons from sensorimotor (SM) and medial prefrontal (mPF) territories, motor asymmetry 
and dopaminergic denervation in sham and 6-OHDA-lesioned rats. 
A. Schematic horizontal sections of the rat brain showing the stimulation of the motor cortex (MC) or the anterior cingulate cortex (ACC), and a representative spike 
trace from SM-SNr or mPF-SNr neurons during single-unit recordings extracellular. The cortical information is transferred through the (Alexander et al., 1986) 
hyperdirect (cortex-STN-SNr, in blue), (Anderson et al., 2020) direct (cortex-striatum-SNr, in red) and (Antonazzo et al., 2019) indirect pathways (cortex-striatum- 
GP-STN-SNr, in green), inducing the characteristic triphasic response in SNr neurons, as illustrated in the peristimulus time histograms. Arrows indicate cortical 
stimulus application. Scale bar for spike traces is of 1 V and 1 ms. B. Left, video frame showing a rat performing the cylinder test. The mean percentage of ipsilateral 
forelimb use represented in the bar graph below shows that 6-OHDA-lesioned rats use more the forelimb ipsilateral to the lesioned side, indicating an important 
degree of motor asymmetry, and suggesting severe dopaminergic denervation. Right, representative brain slices showing TH immunostaining for both sham and 6- 
OHDA-lesioned rats. Note the severe striatal dopaminergic denervation in 6-OHDA rats, after infusion of the toxin in the MFB. The bar graph below shows the TH 
optical density (OD) mean percentage of variation, referring to the change in the hemisphere ipsilateral to the lesion vs. the contralateral side. As depicted in the 
brain slices above, 6-OHDA animals show a severe dopaminergic denervation. Slice scale bars are set to 1 mm. *P < 0.05, two-tailed unpaired Student’s t-test. DL/DM 
striatum: dorsolateral/dorsomedial striatum; GP: globus pallidus; SNr: substantia nigra pars reticulate. (For interpretation of the references to colour in this figure 
legend, the reader is referred to the web version of this article.) 
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2 μg/ml in 10% bovine serum albumin, 0.5% Triton X-100 and 0.1% 
sodium azide in TBS for 20 h. Afterwards, sections were rinsed in 1% 
bovine serum albumin and 0.5% Triton X-100 in TBS and incubated in 
biotinylated horse-anti-goat secondary antibody (Vector BA-9500) 
diluted 15 μg/ml in 1% bovine serum albumin and 0.5% Triton X-100 
in tris buffered saline for 1 h. After secondary antibody incubation, 
sections were again rinsed in 1% bovine serum albumin and 0.5% Triton 
X-100 in TBS saline and reacted for 90 min in ABC complex diluted 
1:1:50 in TBS. After several rinses in PB, the peroxidase reaction with 
0.05% DAB and 0.003% H2O2 in PB was developed for 2 min. Sections 
were rinsed in PB, mounted onto gelatine-coated microscope slides, 
allowed to air dry, dehydrated in graded ethanol, cleared in xylene and 
coverslipped. Microscope slides with the reacted tissue were scanned 
with the 20× objective (NA 0.8; Carl-Zeiss) of a Pannoramic MIDI II 
(3DHISTECH) automatic slide scanner coupled to a CMOS camera (pco. 
edge 4.2, PCO), through an adapter with 1.6× magnification. Images 
were studied with FIJI software using the Bio-Formats plugin (Linkert 
et al., 2010; Schindelin et al., 2012). 
For the analysis of the CB1 receptor density we defined the regions of 
interest (ROI) for each anatomo-functional division in each nucleus 
based on previous tracing, molecular and functional reports, in which 
compartmentalization of the analysed BG nuclei is made depending on 
the cortical information they process. Regarding cortex, we focused on 
the MC and the ACC since they were the target of cortical stimulation in 
electrophysiological experiments. BG nuclei receiving information from 
MC were considered to belong to the SM circuits, and those receiving 
ACC information to the mPF circuits of the BG. MC and ACC ROI’s were 
made following a rat brain atlas (Paxinos and Watson, 2006). Cortical 
areas were analysed until 0.4 mm posterior to bregma, where they were 
considered small enough to be properly selected. Striatal SM and mPF 
territories were limited to those areas receiving afferences from MC and 
ACC, respectively (Heilbronner et al., 2016; McGeorge and Faull, 1989). 
Globus pallidus SM and mPF territories were defined based on calbindin 
expression patterns, which resembles SM and mPF striatal projections 
onto the globus pallidus (Rajakumar et al., 1994). SM-SNr and mPF-SNr 
territories were defined based on functional studies showing connec-
tivity between motor or mPF cortices, respectively (Kolomiets et al., 
2003). For frontal slices the olfactory tract, forceps minor or corpus 
callosum, were selected as background. For more caudal slices, the 
thalamus, geniculate nucleus or reticular formation, were used as 
background. 
To analyze changes in CB1 receptor density between lesion group 
(sham vs. 6-OHDA) and territories (SM or mPF) of the analysed BG 
nuclei, background OD from each hemisphere was subtracted from 
ROI’s OD’s in their corresponding hemisphere. Then values from both 
hemispheres of the same slice, corresponding to a given nucleus and 
territory, were averaged between them; averaged values from all the 
slices in an animal were averaged, so each animal would have two 
values per nucleus: one value for the SM territory, and another for the 
mPF territory. These values corresponding to the same BG territory and 
nucleus were averaged by lesion group. 
2.8. Statistical analysis of data 
The data were analysed using the computer program GraphPad 
Prism (v. 5.01, GraphPad Software, Inc.) and SPSS (v. 25; IBM Corp.). 
Averages from each rat for firing rate, CV and parameters related to 
cortically evoked responses were analysed by a two-tailed unpaired 
Student’s t-test when looking for differences between sham and 6- 
OHDA-lesioned animals in both circuits. Fisher’s exact test was used 
to assess differences in the number of neurons presenting bursting pat-
terns and cortically evoked patterns of response. 
To assess the effects of WIN 55,212-2 on firing rate, CV and pa-
rameters related to cortically evoked responses before and after drug 
application (one neuron per animal), a repeated-measures two-way 
ANOVA was used. When allowable, Bonferroni post-hoc method was 
used for correction of multiple comparisons. Fisher’s exact test was used 
to assess differences in the number of neurons with burst firing before 
and after drug administration. 
To determine the role of the CB1 receptor in the effect of WIN 
55,212-2, the firing rate, CV, and cortically evoked responses pre- 
AM251, post-AM251 and post-AM251 + WIN 55,212-2, were 
compared using a repeated-measures one-way ANOVA in the SM cir-
cuits, and repeated-measures two-way ANOVA in the mPF circuits (one 
neuron per animal), both with Geisser-Greenhouse’s correction if 
epsilon was below 0.75. When allowable, Bonferroni post-hoc method 
was used for correction of multiple comparisons. Differences in the 
number of neurons with burst firing were assessed with the chi-squared 
test. 
CB1 receptor density averages from sham or 6-OHDA rats were 
compared using a two-way ANOVA (lesion × territory) to assess dif-
ferences in CB1 receptor density between territories (SM and mPF) and 
lesion groups (sham and 6-OHDA). When allowable, Bonferroni post-hoc 
method was used for correction of multiple comparisons. 
To assess differences in TH OD and ipsilateral forelimb use between 
sham and 6-OHDA rats a two-tailed unpaired Student’s t-test was used. 
The level of statistical significance was set at P < 0.05. Data are 
presented as group means ± the standard error of the mean (S.E.M.) of n 
rats, unless stated otherwise. 
3. Results 
3.1. Effect of dopaminergic denervation on SNr neuron activity from 
sensorimotor and prefrontal territories 
All recorded cells exhibited the typical electrophysiological charac-
teristics of GABAergic SNr neurons, including a narrow spike waveform 
and a relatively high firing rate (>7 Hz) with a regular pattern of 
discharge and response to cortical stimulation. 
As summarized in Table 1, DA denervation differently affected SM- 
SNr and mPF-SNr neurons: the mean firing rate of mPF-SNr neurons 
was reduced in 6-OHDA-lesioned animals, while the mean firing rate of 
SM-SNr neurons in 6-OHDA-lesioned animals was not affected when 
compared to that of sham rats. Moreover, SM- and mPF-SNr neurons 
from lesioned animals presented a higher coefficient of variation than 
those from sham animals. In addition, the analysis of the firing pattern 
revealed that the number of neurons with bursts was increased in both 
SNr territories of the 6-OHDA-lesioned group. 
As we previously showed, cortical stimulation of the MC or ACC 
evoked characteristic triphasic responses in SNr neurons that consisted 
of an early excitation followed by an inhibition and a late excitation 
(Antonazzo et al., 2019) (Fig. 1A). The presence of the early excitation is 
attributable to the activation of the so-called ‘hyperdirect’ cortico- 
subthalamo-nigral pathway. The activation of the ‘direct’ cortico- 
striato-nigral pathway give rise to the inhibition, and the late excita-
tion derives from the activation of the ‘indirect’ cortico-striato-pallido- 
subthalamo-nigral pathway (Maurice et al., 1999). Different patterns 
of response can be observed in both SNr territories, yielding triphasic, 
biphasic or monophasic cortically evoked responses from the activation 
of the different pathways along the circuits. DA denervation induced 
changes in the percentage of neurons displaying different patterns of 
response in the SM-SNr territory (Table 2): the proportion of neurons 
displaying triphasic and biphasic (i.e., inhibition + late excitation) re-
sponses in SM-SNr neurons was reduced, in favour of more monophasic 
(i.e., early excitation) responses in the 6-OHDA-lesioned group. DA loss 
also altered patterns of response in mPF-SNr neurons, showing a greater 
amount of monophasic – inhibition – responses (Table 2). Overall, SM- 
SNr neurons displayed fewer inhibitions and late excitations, while the 
mPF-SNr neurons displayed only fewer late excitations after DA loss 
(Table 2). 
DA denervation also affected the electrophysiological characteristics 
of cortically evoked responses in SNr neurons (Table 1). SM-SNr cells 
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from 6-OHDA-lesioned animals had early excitations with greater du-
rations than those recorded from sham rats. In the case of mPF-SNr 
neurons, DA denervation increased the latency of the early excitation. 
Moreover, the inhibition appeared later in the SM- and mPF-SNr neurons 
of 6-OHDA-lesioned animals, as indicated by a higher latency. It is 
important to note that, when only triphasic responses were taken into 
account, only the differences in mPF-SNr neurons remained, while no 
differences in electrophysiological characteristics were found in SM-SNr 
neurons between groups (Table S2). 
3.2. Effects of WIN 55,212-2 on cortico-nigral transmission through the 
sensorimotor circuits in sham and 6-OHDA-lesioned rats 
The effect of the synthetic cannabinoid agonist WIN 55,212-2 (WIN) 
(125 μg/kg, i.v.) on the transfer of cortical information through the SM 
circuits in intact and 6-OHDA-lesioned rats was investigated. The dose of 
WIN was carefully selected to minimize any effects on the firing activity 
of SNr neurons, which could make the analysis of the cortically-evoked 
responses difficult. Thus, at the administered dose, WIN did not modify 
the SM-SNr neuron firing rate or the number of neurons with burst ac-
tivity in the sham and 6-OHDA experimental groups, although some 
minor changes were observed regarding the regularity (Table S3). 
According to our previous data (Antonazzo et al., 2019), in sham 
rats, systemic administration of WIN did not alter early excitation but 
diminished cortico-nigral transmission through the indirect pathway, as 
shown by a reduction in the amplitude of the late excitation. However, 
no statistically significant decrease was observed in the transmission 
through the direct pathway (Fig. 2). In contrast to that observed in the 
sham group, 6-OHDA lesions modified the effect of WIN on cortico- 
nigral transmission through the SM circuits, being the early excitation 
decreased after drug administration. However, cortico-nigral informa-
tion transfer through the trans-striatal pathways was not affected after 
WIN administration in 6-OHDA-lesioned animals (Fig. 2). 
The effects observed in sham rats were blocked by the previous 
administration of the CB1-selective antagonist AM251 (2 mg/kg, i.v.) 
(Fig. 3). AM251 alone did not modify the cortico-nigral information 
transfer (Fig. 3) or the spontaneous activity of SM-SNr neurons (Table 
S4). 
3.3. Effects of WIN 55,212-2 on cortico-nigral transmission through the 
medial prefrontal circuits in sham and 6-OHDA-lesioned rats 
We further explored the effect of WIN (125 μg/kg, i.v.) on cortico- 
nigral transmission through the mPF circuits in intact and 6-OHDA- 
lesioned rats. At the administered dose, WIN did not modify the mPF- 
SNr neuronal firing rate or the number of neurons displaying burst ac-
tivity. Nevertheless, some minor changes were observed regarding reg-
ularity (Table S3). 
As previously shown in control animals (Antonazzo et al., 2019), 
WIN administration dramatically impaired all cortically evoked re-
sponses, reducing the amplitude of the early and late excitations and the 
duration of the inhibition (Fig. 4). As in SM circuits, DA denervation 
induced changes in the way WIN modulates transmission through the 
mPF circuits. The administration of WIN reduced the amplitude of the 
early excitation but had no effect on cortical information transfer 
through the direct and indirect pathways (Fig. 4). 
These effects were blocked by the previous administration of the 
CB1-selective antagonist AM251 (2 mg/kg, i.v.) in both sham and 6- 
OHDA-lesioned animals (Fig. 5). AM251 alone did not modify the 
cortico-nigral information transfer (Fig. 5) or the spontaneous activity of 
mPF-SNr neurons (Table S4). 
3.4. CB1 receptor localization in the sensorimotor and prefrontal circuits 
of the basal ganglia in sham and 6-OHDA-lesioned rats 
Finally, CB1 immunostaining was performed in all BG structures 
Table 1 
Electrophysiological characteristics of the spontaneous and cortically-evoked 
responses in neurons from the sensorimotor (SM) and medial prefrontal (mPF) 
subdivisions of the substantia nigra pars reticulata (SNr) in sham and 6-OHDA- 
lesioned rats.   









Firing rate (Hz) 21.2 ±
1.8 
19.0 ± 1.2 24.8 ±
1.3 
19.4 ± 1.0* 








Burst firing neurons/ 
recorded neurons 
51/98 91/115 126/187 144/160 
Neurons exhibiting burst 
firing pattern (%) 
52.0 79.1* 67.4 89.6*  
Early excitation n = 19 n = 27 n = 30 n = 28 
Duration (ms) 5.3 ± 0.4 8.3 ± 1.0* 7.2 ± 0.7 6.4 ± 1.0 
Latency (ms) 5.5 ± 0.4 5.7 ± 0.3 8.5 ± 0.6 13.7 ± 0.5* 
Amplitude 14.4 ±
1.3 
13.2 ± 0.8 8.2 ± 0.5 7.9 ± 0.8  
Inhibition n = 20 n = 29 n = 32 n = 38 
Duration (ms) 19.8 ±
2.1 
27.6 ± 4.6 11.5 ±
0.8 
13.0 ± 1.7 
Latency (ms) 12.1 ±
0.4 
14.0 ± 0.4* 18.8 ±
0.4 
20.8 ± 0.4*  
Late excitation n = 21 n = 29 n = 32 n = 38 
Duration (ms) 6.0 ± 0.5 7.5 ± 0.7 11.2 ±
0.8 
11.3 ± 0.9 
Latency (ms) 27.1 ±
0.6 
27.7 ± 0.7 33.4 ±
0.4 
33.5 ± 0.5 
Amplitude 17.9 ±
2.5 
13.7 ± 1.5 15.4 ±
1.0 
13.8 ± 0.8 
Each value represents the mean ± S.E.M. of (n) recorded rats. 
* P < 0.05 Sham vs. 6-OHDA (Firing rate, coefficient of variation and response 
parameters: two-tailed unpaired Student’s t-test; neurons exhibiting burst firing 
pattern: Fisher’s exact test). 
Table 2 
Percentage of occurrence the different patterns of responses evoked in substantia 
nigra pars reticulata (SNr) neurons by motor or medial prefrontal cortex stimu-
lation in sham and 6-OHDA-lesioned animals.   









Total no. neurons 
showing early 
excitation (%) 
60.2 66.1 30.5 28.1 
Total no. neurons 
showing inhibition (%) 
75.5 51.3* 65.8 70.6 
Total no. neurons 
showing late excitation 
(%) 
65.3 46.1* 86.1 70.6* 
Patterns of responses (%)     
Triphasic response 29.6 16.5* 19.8 11.9 
Early excitation +
Inhibition 
21.4 22.6 3.2 5 
Inhibition + Late 
excitation 
16.3 3.5* 38 36.9 
Early excitation + Late 
excitation 
4.1 4.3 1.6 3.8 
Early excitation 5.1 22.6* 5.9 7.5 
Inhibition 8.2 8.7 4.8 16.9* 
Late excitation 15.3 21.7 26.7 18.1 
Each value represents the number of neurons exhibiting the response to cortical 
stimulation (% of n recorded neurons). 
* P < 0.05 vs sham, Fisher’s exact test. 
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included in the SM and mPF circuits. The study of the mean OD obtained 
from all the slices through each structure, and the comparison between 
the divisions related to the SM and mPF circuits for every nucleus 
sampled revealed some differences. In the striatum from sham animals, 
the CB1-positive labelling in the lateral division related to the SM circuit 
was higher than in the mPF-related division. This difference was also 
statistically significant in 6-OHDA-lesioned animals (Fig. 6). 
On the other hand, no statistically significant changes were found in 
the CB1 receptor immunostaining between sham and 6-OHDA-lesioned 
rats, in any of the analysed territories of the BG nuclei (Fig. 7). 
4. Discussion 
In the present study, we investigated the functioning of BG circuits 
and their modulation by the CB1 receptor under DA-depleted condi-
tions. The results show that the DA deficit modifies the transmission 
through the SM and mPF circuits. Moreover, we observed an alteration 
at the level of CB1 receptors modulating cortico-BG information transfer 
in 6-OHDA-lesioned animals. Given the role of these circuits in motor 
and cognitive/motivational information processing, the present data 
may help researchers to understand the role of the cannabinoid system 
in motor and non-motor symptoms associated with the hypo-
dopaminergic state. 
4.1. Spontaneous and cortically evoked SNr neuron activity after DA 
denervation 
According to our data, in DA-depleted animals, SNr neurons recor-
ded in the mPF and SM regions exhibited alterations in spontaneous 
activity, displaying more irregular and burst firing patterns (Aristieta 
et al., 2016; Vegas-Suárez et al., 2020). However, only in the mPF-SNr 
neurons did we observe a significant reduction in the firing rate. In 
line with our results, Wang et al. (2010) showed a decreased firing rate 
and an increased CV and burst activity in mPF-SNr neurons in animals 
injected with 6-OHDA in the MFB. Regarding the SM territory, there is 
much more evidence supporting the hyperactive SNr neuronal discharge 
pattern after DA depletion, without changes in the firing rate (Aristieta 
et al., 2016; Maurice et al., 2015; Meissner et al., 2006; Murer et al., 
1997; Tseng et al., 2000). Several studies suggest that there might be a 
mediolateral gradient in DA content in the SNr, with less DA in the SM- 
SNr and more DA in the mPF-SNr (Ciliax et al., 1995; Cragg et al., 1997; 
Rice et al., 1994, 1997; Weiss-Wunder and Chesselet, 1990). This sug-
gestion is in accordance with the greater effect of DA denervation 
observed on the firing rate and pattern of mPF-SNr neurons. Our data 
suggest that mPF-SNr neurons rely more on DA for their normal function 
than SM-SNr neurons. The effects of DA denervation on SNr spontaneous 
activity likely involve an indirect mechanism, like modulation of pre-
synaptic GABAergic or glutamatergic inputs, since SNr neurons lack 
Fig. 2. Effect of systemic administration of WIN 55,212-2 (125 μg/kg, i.v.) on cortico-nigral information transmission in sensorimotor (SM) BG circuits in sham and 
6-OHDA-lesioned animals. 
A. Top, raster plot and peristimulus time histogram showing a representative example of a triphasic response evoked in an SM-SNr neuron from a sham rat through 
the stimulation of the motor cortex (MC) under basal conditions. Bottom, after WIN 55,212-2 injection, the inhibitory and late excitatory components disappeared, 
with the early excitation remaining unaltered. Arrows indicate cortical stimulus application. Dashed lines indicate the threshold for excitatory responses. C. Top, 
raster plot and peristimulus time histogram showing a representative example of a triphasic response evoked in an SM-SNr neuron from a 6-OHDA-lesioned animal 
through the stimulation of the motor cortex under basal conditions. Bottom, after WIN 55,212-2 injection, none of the three pathways experienced any change in 
transmission in 6-OHDA-denervated animals. Arrows indicate cortical stimulus application. Dashed lines indicate the threshold for excitatory responses. B. Bar 
graphs showing the mean effect of WIN 55,212-2 (125 μg/kg, i.v.) on cortically evoked responses in SM-SNr neurons (amplitude of early (EE; sham: n = 5; 6-OHDA: 
n = 6) and late (LE; sham: n = 5; 6-OHDA: n = 6) excitations and the duration of inhibition (INH; sham: n = 6; 6-OHDA: n = 6)) in SM circuits. Each bar represents 
the mean ± the S.E.M. of n rats. Each dot represents the value from one neuron before and after drug administration. *P < 0.05 before vs. after WIN, repeated- 
measures two-way ANOVA (Drug x Lesion). 
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postsynaptic DA receptors (Yung et al., 1995). According to the classical 
BG organization model, the direct striatonigral pathway is under the 
control of DA projections via D1 receptors, whereas the striato-pallido- 
subthalamo-nigral indirect pathway is controlled via D2 receptors. 
Degeneration of nigrostriatal DA neurons results in a dramatic decrease 
of striatal DA level and, subsequently, in a supersensitivity of the striatal 
postsynaptic DA receptors affecting the direct and indirect pathways and 
triggering SNr neuron activity abnormalities (Galvan and Wichmann, 
2008). Thus, in line with our previous data, SNr neurons recorded in the 
mPF and SM regions from 6-OHDA lesioned animals displayed more 
irregular and burst firing patterns, probably related with the well 
described hyperactivated subthalamic nucleus after DA depletion. 
Moreover, in mPF-SNr neurons we observed a significant reduction in 
the firing rate that might be due to an increase in the number of D2 
receptors in the limbic striatum after striatal DA depletion, which acti-
vation inhibits SNr neuronal firing via their intracellular effects on Gi 
proteins (Lévesque et al., 1995). 
In relation to the SM circuit, we show a prominent transmission 
through the hyperdirect trans-subthalamic pathway reflected by a 
greater mean duration and more monophasic early excitations. These 
data differ, at least in part, from the evidence available to date, although 
the heterogeneous results may depend on methodological differences 
like the use of different anaesthetic regime (chloral hydrate, urethane or 
awake animals) (Beyeler et al., 2010; Heckman et al., 2018; Kolomiets 
et al., 2003; Maurice et al., 1999; Sano and Nambu, 2019), or dopami-
nergic interruption method (6-OHDA lesion or pharmacological 
blockade) (Degos et al., 2005; Sano and Nambu, 2019). Moreover, the 
degree of dopaminergic denervation, and time after the 6-OHDA injec-
tion, may also impact on results. 
Degos et al. (2005) studied the effect of acute pharmacological 
blockade of DA transmission on circuit functionality, but by systemic 
injection of neuroleptics. They showed decreased transmission through 
the direct pathway and a reinforced transmission through the indirect 
pathway, without any change in the information transfer through the 
hyperdirect pathway. Using the 6-OHDA neurotoxin, other authors 
either have found no alterations (injected into the substantia nigra pars 
compacta) (Maurice et al., 2015) or have described early excitations as 
the predominant response after dopaminergic denervation (injected into 
the MFB, but recordings in awake mice) (Sano and Nambu, 2019). 
However, although this might be in accordance with our results, the 
authors also found an increase in transmission through the indirect 
pathway, concluding that only neuronal transduction through the direct 
pathway is diminished in PD. Predominant transmission through the 
hyperdirect pathway in the SM circuit observed in the present study, 
together with the hyperactivity of SM-SNr neurons, is consistent with 
the overactive state of the subthalamic nucleus extensively described 
under low DA conditions and has been related to the motor features of 
parkinsonism (Benabid et al., 1994; Bergman et al., 1994; Hassani et al., 
1996; Steigerwald et al., 2008). 
To our knowledge, the present is the first demonstration that DA 
denervation alters the cortically evoked responses in mPF-SNr neurons, 
leading to a predominant information transfer though the direct 
pathway, with a loss of efficacy in the transmission through the hyper-
direct and indirect pathways (augmented latency of early excitations or 
Fig. 3. Blockade of WIN 55,212-2-induced effects on cortico-nigral information transmission in sensorimotor (SM) BG circuits in sham animals by the previous 
administration of the CB1 selective antagonist AM251 (2 mg/kg, i.v.). 
A. Left, raster plot and peristimulus time histogram showing a representative example of a triphasic response evoked in a SM-SNr neuron by stimulation of the motor 
cortex (MC) in a sham rat under basal conditions. AM251 administration did not modify the characteristics of the three components of the cortically evoked response 
(middle) but blocked the effects induced by WIN 55,212-2 (right). Arrows indicate cortical stimulus application. Dashed lines indicate threshold for excitatory 
responses. B. Bar graphs showing the mean effect of AM251 (2 mg/kg, i.v.) and WIN 55,212-2 (125 μg/kg, i.v.) on cortically evoked responses in SM-SNr neurons 
(amplitude of early (EE; n = 4) and late (LE; n = 4) excitations and duration of inhibition (INH; n = 4)) in SM circuits. Each bar represents the mean ± S.E.M. of n rats. 
Each dot represents the value from one neuron before and after drug administration. 
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less late excitations). These data, together with the important modifi-
cations of the spontaneous activity of mPF-SNr neurons, indicate 
abnormal functionality inside associative and limbic territories of the 
BG. In fact, behavioural studies performed in similar PD models show 
cognitive dysfunctions, such as apathy (Anderson et al., 2020; Carvalho 
et al., 2013; Furlanetti et al., 2015) or depression-like behaviours 
(Winter et al., 2007; Zhang et al., 2011), that are linked to the BG and 
are present in PD patients (Tremblay et al., 2015). Thus, the alterations 
observed in this study in the mPF circuits after DA denervation might 
help understand the neurobiological components behind these motiva-
tional symptoms in PD patients. 
Overall, our results indicate that DA depletion along with probable 
compensatory changes induced by DA denervation itself, lead to deficits 
in cortical information selection through the segregated anatomo- 
functional cortico-BG loops. In the mPF circuits, the information 
through the direct pathway is enhanced, while in the SM circuits, the 
enhancement takes place in the hyperdirect pathway. Although, in 
principle, these data would not be in line with studies showing striatal 
medium spiny neurons (MSN) hyperactivation (both those expressing 
D1 (dMSN) and those expressing D2 receptors (iMSN)) in animal models 
and PD patients (Fieblinger et al., 2014; Singh et al., 2016; Suarez et al., 
2016), other factors could influence the output of the circuits seen in SNr 
neurons after cortical stimulation. Some studies point out alterations 
during hypodopaminergic states such as dendritic atrophy, spine prun-
ing and reduced corticostriatal glutamatergic synapses in dMSN, iMSN 
or both MSN’s that could be reducing cortical input on these neurons 
(Fieblinger et al., 2014; Gagnon et al., 2017; Graves and Surmeier, 2019; 
Suarez et al., 2016). Moreover, functional studies show a decreased 
corticostriatal connectivity in dMSN’s, and increased in iMSN’s in a 6- 
OHDA model similar to ours, in line with the classical model of BG 
function in hypodopaminergic states (Escande et al., 2016; Mallet et al., 
2006). Overall, this evidence would support the reduced percentage of 
neurons displaying direct pathway activation (inhibitory component of 
the cortically-evoked response in SNr neurons) that we observe in the 
SM circuits of 6-OHDA animals. However, the reduced transmission 
through the indirect pathway of the SM circuits in lesioned group is 
contradictory. Being the indirect pathway a polysynaptic pathway, 
interpretation of the effects of DA denervation grows in complexity, 
especially if we consider the impact of the DA loss in pallidal and sub-
thalamic function (Chan et al., 2011; Magill et al., 2001; Miguelez et al., 
2012). Moreover, one characteristic of the BG nuclei is the high synaptic 
convergence in its output nuclei. Mallet et al. (2006) showed that DA 
denervation increases the time window in which iMSN’s respond to 
stimulation of the MC. This variability in the response time of iMSN’s 
after cortical stimulation could make the summation of multiple inputs 
on neurons in downstream nuclei difficult, failing to engage neuronal 
activity efficiently, and provoke full transmission through the indirect 
pathway, reaching the SNr. 
Regarding the mPF circuits, we observed only a decrease in the 
number of neurons showing a late excitation, related with decreased 
indirect pathway activation. Most of the studies discussed above address 
how BG physiology is altered in hypodopaminergic states with special 
Fig. 4. Effect of systemic administration of WIN 55,212-2 (125 μg/kg, i.v.) on cortico-nigral information transmission in medial prefrontal (mPF) BG circuits in sham 
and 6-OHDA-lesioned animals. 
A. Top, raster plot and peristimulus time histogram showing a representative example of a triphasic response evoked in an mPF-SNr neuron from a sham rat through 
the stimulation of the anterior cingulate cortex (ACC) under basal conditions. Bottom, WIN 55,212-2 injection was able to reduce transmission through the three 
pathways. Arrows indicate cortical stimulus application. Dashed lines indicate the threshold for excitatory responses. C. Top, raster plot and peristimulus time 
histogram showing a representative example of a triphasic response evoked in an mPF-SNr neuron from a 6-OHDA-lesioned animal through the stimulation of the 
ACC under basal conditions. Bottom, after WIN 55,212-2 injection, only reduced transmission of the early excitation in 6-OHDA-denervated animals was observed. 
Arrows indicate cortical stimulus application. Dashed lines indicate the threshold for excitatory responses. B. Bar graphs showing the mean effect of WIN 55,212-2 
(125 μg/kg, i.v.) on cortically evoked responses in mPF-SNr neurons (amplitude of early (EE; sham: n = 6; 6-OHDA: n = 5) and late (LE; sham: n = 8; 6-OHDA: n = 6) 
excitations and the duration of inhibition (INH; sham: n = 7; 6-OHDA: n = 5)) in mPF circuits. Each bar represents the mean ± the S.E.M. of n rats. Each dot 
represents the value from one neuron before and after drug administration. *P < 0.05 before vs. after WIN, repeated-measures two-way ANOVA (Drug x Lesion). 
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emphasis on the SM territories, but few have addressed this same topic 
on the mPF territories of the BG. Some studies manifest substantial 
differences between SM and mPF territories. For instance, sensory- and 
limbic-related cortical areas preferentially innervate dMSN’s, whilst 
motor-related areas innervate iMSN’s (Wall et al., 2013). Moreover, 
functional studies have shown different forms of plasticity taking place 
under different conditions in SM and mPF territories of the striatum, 
besides differences in components from key striatal neurotransmitter 
systems (Arbuthnott and Wickens, 2007; Atwood et al., 2014; Braz et al., 
2017; Herkenham et al., 1991). Together, this evidence calls for caution 
in extrapolating traits related with components from the SM circuits, 
into components from the mPF circuits. These differences could affect 
the way mPF circuits behaves, not only under physiological conditions, 
but also in pathological states, therefore stepping aside from what is 
expected from BG physiology under DA denervation. 
The abnormal selectivity of information affecting motor, cognitive 
and motivational domains could be the neurophysiological impetus to 
the development of the motor and non-motor symptoms observed in PD, 
and it can be due to reduced anatomical and functional connectivity in 
cortico-BG networks, as demonstrated in PD patients and more evident 
for SM connections (Sharman et al., 2013). 
4.2. Dysfunctional CB1-mediated modulation of cortico-BG information 
transmission 
CB1-mediated modulation of cortical information transmission 
through the SM or mPF BG circuits is changed in 6-OHDA-lesioned an-
imals. In agreement with our previous work in control animals (Anto-
nazzo et al., 2019), administration of WIN in sham rats caused a 
reduction in the information transmission through the indirect pathway, 
without affecting the hyperdirect pathway in the SM circuits. Regarding 
the mPF circuits, administration of WIN in sham rats decreased infor-
mation transmission through the three pathways. However, no statisti-
cally significant reduction of the transmission through the direct 
pathway was observed in this study in the SM circuits, in contrast to our 
previous work in control animals. This could be due to the extreme value 
present in the 6-OHDA dataset, which could likely be introducing noise, 
therefore confusing the statistical test. In support of this, data obtained 
here and in our previous work (Antonazzo et al., 2019) before and after 
WIN administration is similar, both mean and dispersion values (Before 
WIN: 12.3 ± 2.6 vs. 15.0 ± 1.5; After WIN: 3.5 ± 2.3 vs. 4.4 ± 2.1). 
After dopaminergic denervation, the hyperdirect pathway in the SM 
circuits became sensitive to WIN administration. Previous work in our 
lab shows that administration of WIN in 6-OHDA-lesioned rats reduces 
Fig. 5. Blockade of WIN 55,212-2-induced effects on cortico-nigral information transmission in medial prefrontal (mPF) BG circuits in sham and 6-OHDA-lesioned 
animals by the previous administration of the CB1 selective antagonist AM251 (2 mg/kg, i.v.). 
A. Top, raster plot and peristimulus time histogram showing a representative example of a triphasic response evoked in a mPF-SNr neuron by stimulation of the 
anterior cingulate cortex (ACC) in a sham rat under basal conditions. AM251 administration did not modify the characteristics of the three components of the 
cortically evoked response (middle) but blocked the effects induced by WIN 55,212-2 (bottom). Arrows indicate cortical stimulus application. Dashed lines indicate 
threshold for excitatory responses. C. Top, raster plot and peristimulus time histogram showing a representative example of a triphasic response evoked in a mPF-SNr 
neuron by stimulation of the ACC in a 6-OHDA rat under basal conditions. AM251 administration did not modify the characteristics of the three components of the 
cortically evoked response (middle) but blocked the effects induced by WIN 55,212-2 (bottom). Arrows indicate cortical stimulus application. Dashed lines indicate 
threshold for excitatory responses. B. Bar graphs showing the mean effect of AM251 (2 mg/kg, i.v.) and WIN 55,212-2 (125 μg/kg, i.v.) on cortically evoked responses 
in mPF-SNr neurons (amplitude of early (EE; sham: n = 5; 6-OHDA: n = 5) and late (LE; sham: n = 5; 6-OHDA: n = 5) excitations and duration of inhibition (INH; 
sham: n = 5; 6-OHDA: n = 6) in mPF circuits. Each bar represents the mean ± S.E.M. of n rats. Each dot represents the value from one neuron before and after drug 
administration. 
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Fig. 6. CB1 receptor immunoreactivity in the sensorimotor (SM) and medial prefrontal (mPF) basal ganglia territories in the cortex, striatum, globus pallidus and 
substantia nigra pars reticulate from sham and 6-OHDA-lesioned rats. 
A. Representative sham rat (top) and 6-OHDA-lesioned (bottom) rats brain slices showing CB1 receptor immunoreactivity in the studied areas. SM and mPF analysed 
territories are marked in purple and green, respectively. B. Bar graphs showing the mean CB1 receptor optical density (OD) in the SM and mPF territories of the 
studied brain areas in sham and 6-OHDA-lesioned animals. Note that there is significantly less CB1 receptor immunoreactivity in the mPF territories of the striatum in 
both sham and 6-OHDA-lesioned animals compared to SM territories. Scale bars are set to 1 mm. Each bar represents the mean ± the S.E.M. of n rats. Each dot 
represents the averaged value from one rat. *P < 0.05 SM vs. mPF, repeated-measures two-way ANOVA (Territory × Lesion). (For interpretation of the references to 
colour in this figure legend, the reader is referred to the web version of this article.) 
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firing rate of subthalamic nucleus neurons (Morera-Herreras et al., 
2011), which could explain the reduced transmission through the 
hyperdirect pathway after WIN administration in these circuits. In the 
mPF circuits, this pathway remains sensitive to WIN in the 6-OHDA 
group. However, trans-striatal pathways in both circuits became insen-
sitive to WIN after DA denervation. 
A possible explanation for the observed findings could be the alter-
ation of CB1 receptor expression induced by DA depletion. For this 
reason, we decided to perform immunohistochemical assays to deter-
mine the precise territory-specific potential changes in each nucleus 
conforming the BG circuits. In sham animals, sub-territorial immuno-
labelling analysis revealed predominant CB1 expression in the SM areas 
of the striatum compared to associative/limbic striatal regions. These 
data is consistent with previous work reported by other authors (A. G. 
Hohmann and Herkenham, 1999; Mailleux and Vanderhaeghen, 1992; 
Marsicano and Lutz, 1999; Matsuda et al., 1993; Van Waes et al., 2012; 
Zimmer et al., 1999), overall suggesting that CB1 receptors located in 
these anatomical regions of the BG could predominantly regulate SM 
information processing, or at least to a greater extent than mPF re-
ceptors. In the SM areas of the striatum, and given the preferential 
location of the CB1 receptor on terminals (Irving et al., 2000), extensive 
location of the CB1 receptor in SM territories likely comes from MSN’s 
axon collaterals. Therefore, contributions from striatal afferents to CB1 
immunostaining in SM territories is probably minimal. Although the 
CB1 receptor is expressed in cortical areas projecting to SM territories of 
the striatum, this expression is modest, and located principally in non- 
pyramidal neurons (Heng et al., 2011; Mailleux and Vanderhaeghen, 
1992). Moreover, midbrain dopaminergic neurons and thalamic neurons 
show negligible levels of CB1 expression (Herkenham et al., 1991; 
Mailleux and Vanderhaeghen, 1992). This is in line with the sparse CB1 
presence in mPF territories of the striatum, where the expression of this 
receptor is also minimal (Hohmann and Herkenham, 2000; Van Waes 
Fig. 7. Regional distribution of CB1 receptor expression in the basal ganglia nuclei from 6-OHDA-lesioned rats. 
Brain microphotographs of coronal sections showing the CB1 receptor immunohistochemistry. The first row shows the distribution of the CB1 receptor in the motor 
cortex (MC) and anterior cingulate cortex (ACC). Second row shows the sensorimotor territory (dorsolateral striatum; SM-Str) and the medial prefrontal territory 
(dorsomedial striatum; mPF-Str). Third row shows the globus pallidus divided in its sensorimotor (SM-GP) and medial prefrontal territory (mPF-GP), and the sus-
bstantia nigra (SN). Studied areas are shown in pairs, being the pictures on the left from the lesioned hemisphere. Scale bars are set to 500 μm. 
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et al., 2012). In this case, sparse CB1 immunostaining would likely come 
from afferences like mPF cortical areas, and to some extent hippocampus 
and amygdala where CB1 receptor is highly expressed (Herkenham 
et al., 1991; Mailleux and Vanderhaeghen, 1992; Voorn et al., 2004). 
Overall, contribution to CB1 immunostaining from striatal interneurons 
is probably low since they represent <3% of the total number of striatal 
neurons, regardless that some of them express CB1 receptor (Hohmann 
and Herkenham, 2000; Martín et al., 2008; Oorschot et al., 2002). 
Additionally, we did not find any topographical difference in CB1 
receptor expression under conditions of low DA, although the higher 
CB1 expression in the striatal SM area was preserved compared to the 
mPF. In agreement with our observations, using the unilateral-MFB 6- 
OHDA rat model, no changes in CB1 receptor binding in the BG have 
been described, measured by [3H]-WIN-55,212-2 autoradiography 
7–10 weeks after the lesion (Romero et al., 2000), by immunohisto-
chemistry at different post-lesion time points (Walsh et al., 2010), or by 
mRNA in situ hybridization histochemistry (Zeng et al., 1999). More 
recently, similar results have been reported in MPTP parkinsonian 
monkeys (Rojo-Bustamante et al., 2018). Data coming from post-mortem 
brain tissue of PD patients are inconclusive, showing increased (Lastres- 
Becker et al., 2001) or no changes (Farkas et al., 2012) in CB1 receptor 
binding or decreased receptor expression measured through mRNA 
(Hurley et al., 2003). 
Taking into account these results, we can conclude that, in our 
experimental conditions, CB1 receptor expression in BG nuclei is not 
affected by DA denervation, indicating that the loss of cannabinoid 
modulation of cortico-BG circuits could be due to a mechanism related 
to an alteration of CB1 receptor functionality. In this aspect, current 
evidence also shows some discrepancies, describing increased activation 
of GTP-binding proteins in PD patients treated with L-DOPA and MPTP 
marmosets (Lastres-Becker et al., 2001) as well as no changes in 6- 
OHDA-lesioned rats (Romero et al., 2000). In our experimental model, 
and according to the observed results, we hypothesize that after 4–5 
weeks of DA depletion induced by unilateral-MFB 6-OHDA injection, 
CB1 receptor hyposensitivity occurs within the cortico-BG circuits, 
which could explain the lack of the modulation of these networks. 
5. Conclusions 
In summary, the present study allows us to better understand the 
non-motor functions of the BG and highlights not only dysfunctional 
motor information processing though the cortico-BG circuits but also 
abnormal information transfer through the associative/limbic domains 
after DA loss. This unusual mPF BG circuitry functionality could be 
related to the cognitive deficits and behavioural disorders that occur in 
PD. Therefore, the targeting of limbic/associative BG circuits and the 
restoration of CB1 functionality could constitute a promising target for 
the treatment of these non-motor symptoms manifested by PD patients. 
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Halldin, C., Máthé, D., Csiba, L., Gulyás, B., 2012. The decrease of dopamine D 2/D 3 
receptor densities in the putamen and nucleus caudatus goes parallel with 
maintained levels of CB 1 cannabinoid receptors in Parkinson’s disease: a 
preliminary autoradiographic study with the selective dopamine D 2/D 3 ant. Brain 
Res. Bull. 87 (6), 504–510. https://doi.org/10.1016/j.brainresbull.2012.02.012. 
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Köfalvi, A., Rodrigues, R.J., Ledent, C., Mackie, K., Vizi, E.S., Cunha, R.A., Sperlágh, B., 
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Romero, J., Berrendero, F., Pérez-Rosado, A., Manzanares, J., Rojo, A., Fernández- 
Ruiz, J.J., de Yebenes, J.G., Ramos, J.A., 2000. Unilateral 6-hydroxydopamine 
lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in 
the caudate-putamen. Life Sci. 66 (6), 485–494. https://doi.org/10.1016/S0024- 
3205(99)00618-9. 
Romero, Julián, Lastres-Becker, I., De Miguel, R., Berrendero, F., Ramos, J.A., Fernández- 
Ruiz, J., 2002. The endogenous cannabinoid system and the basal ganglia: 
biochemical, pharmacological, and therapeutic aspects. Pharmacol. Ther. 95 (2), 
137–152. https://doi.org/10.1016/S0163-7258(02)00253-X. 
Sano, H., Nambu, A., 2019. The effects of zonisamide on L-DOPA–induced dyskinesia in 
Parkinson’s disease model mice. Neurochem. Int. 124, 171–180. https://doi.org/ 
10.1016/j.neuint.2019.01.011. 
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., 
Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., Tinevez, J.-Y., White, D.J., 
Hartenstein, V., Eliceiri, K., Tomancak, P., Cardona, A., 2012. Fiji: an open-source 
platform for biological-image analysis. Nat. Methods 9 (7), 676–682. https://doi. 
org/10.1038/nmeth.2019. 
Schreiner, A.M., Dunn, M.E., 2012. Residual effects of cannabis use on neurocognitive 
performance after prolonged abstinence: a meta-analysis. Exp. Clin. 
Psychopharmacol. 20 (5), 420–429. https://doi.org/10.1037/a0029117. 
Sharman, M., Valabregue, R., Perlbarg, V., Marrakchi-Kacem, L., Vidailhet, M., 
Benali, H., Brice, A., Lehéricy, S., 2013. Parkinson’s disease patients show reduced 
cortical-subcortical sensorimotor connectivity. Mov. Disord. 28 (4), 447–454. 
https://doi.org/10.1002/mds.25255. 
Singh, A., Mewes, K., Gross, R.E., DeLong, M.R., Obeso, J.A., Papa, S.M., 2016. Human 
striatal recordings reveal abnormal discharge of projection neurons in Parkinson’s 
disease. Proc. Natl. Acad. Sci. U. S. A. 113 (34), 9629–9634. https://doi.org/ 
10.1073/pnas.1606792113. 
Steigerwald, F., Pötter, M., Herzog, J., Pinsker, M., Kopper, F., Mehdorn, H., Deuschl, G., 
Volkmann, J., 2008. Neuronal activity of the human subthalamic nucleus in the 
parkinsonian and nonparkinsonian state. J. Neurophysiol. 100 (5), 2515–2524. 
https://doi.org/10.1152/jn.90574.2008. 
Suarez, L.M., Solis, O., Aguado, C., Lujan, R., Moratalla, R., 2016. L-DOPA oppositely 
regulates synaptic strength and spine morphology in D1 and D2 striatal projection 
neurons in dyskinesia. Cereb. Cortex 26 (11), 4253–4264. https://doi.org/10.1093/ 
cercor/bhw263. 
Tremblay, L., Worbe, Y., Thobois, S., Sgambato-Faure, V., Féger, J., 2015. Selective 
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